🇺🇸 FDA

Intelligence Platform

Patents

Browse 5 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9107912

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8742129

Crystalline forms of febuxostat

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609856

Crystalline forms of Febuxostat

Teva Pharmaceuticals USA, Inc. · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415481

Crystalline form of febuxostat

Teva Pharmaceuticals USA, Inc. · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372872

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted